Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP616582.RAwnQZWagJOQBGigv4KtagJl465o9aCJXbYz_Jta18nso130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP616582.RAwnQZWagJOQBGigv4KtagJl465o9aCJXbYz_Jta18nso130_assertion type Assertion NP616582.RAwnQZWagJOQBGigv4KtagJl465o9aCJXbYz_Jta18nso130_head.
- NP616582.RAwnQZWagJOQBGigv4KtagJl465o9aCJXbYz_Jta18nso130_assertion description "[The small molecule ET(A)R antagonist achieves concomitant suppression of tumor growth and EMT effectors, providing a new opportunity for therapeutic intervention in which targeting ILK pathway and the related Snail and beta-catenin signaling cascade via ET(A)R blockade may be advantageous in the treatment of ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP616582.RAwnQZWagJOQBGigv4KtagJl465o9aCJXbYz_Jta18nso130_provenance.
- NP616582.RAwnQZWagJOQBGigv4KtagJl465o9aCJXbYz_Jta18nso130_assertion evidence source_evidence_literature NP616582.RAwnQZWagJOQBGigv4KtagJl465o9aCJXbYz_Jta18nso130_provenance.
- NP616582.RAwnQZWagJOQBGigv4KtagJl465o9aCJXbYz_Jta18nso130_assertion SIO_000772 17587812 NP616582.RAwnQZWagJOQBGigv4KtagJl465o9aCJXbYz_Jta18nso130_provenance.
- NP616582.RAwnQZWagJOQBGigv4KtagJl465o9aCJXbYz_Jta18nso130_assertion wasDerivedFrom befree-2016 NP616582.RAwnQZWagJOQBGigv4KtagJl465o9aCJXbYz_Jta18nso130_provenance.
- NP616582.RAwnQZWagJOQBGigv4KtagJl465o9aCJXbYz_Jta18nso130_assertion wasGeneratedBy ECO_0000203 NP616582.RAwnQZWagJOQBGigv4KtagJl465o9aCJXbYz_Jta18nso130_provenance.